HS
KNSA icon

HighVista Strategies’s Kiniksa Pharmaceuticals KNSA Stock Holding History

HighVista Strategies’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-74,639
Closed -$1.66M – 163
2025
Q1 		$1.66M Hold
74,639
– – 0.64% 54
2024
Q4 		$1.48M Hold
74,639
– – 0.55% 70
2024
Q3 		$1.87M Sell
74,639
-14,049
-16% -$342K 0.64% 53
2024
Q2 		$1.66M Hold
88,688
– – 0.6% 59
2024
Q1 		$1.75M Hold
88,688
– – 0.62% 54
2023
Q4 		$1.56M Buy
+88,688
New +$1.46M 0.56% 62

Other funds holding KNSA

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

HighVista Strategies's KNSA Position: Q2 2025 in Review

HighVista Strategies sold out of Kiniksa Pharmaceuticals (KNSA) in Q2 2025, closing a stake of 74,639 shares — an estimated $1.66M sold.

HighVista Strategies first reported a position in KNSA in Q4 2023 and held it in 6 quarters. The position peaked at $1.87M in Q3 2024. 189 funds tracked by Wall St. Rank hold KNSA as of Q2 2025.

  • HighVista Strategies reported no remaining Kiniksa Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • HighVista Strategies sold 74,639 Kiniksa Pharmaceuticals shares in Q2 2025, an estimated $1.66M.
  • HighVista Strategies first reported a position in Kiniksa Pharmaceuticals in Q4 2023 and held it in 6 quarters.
  • HighVista Strategies's Kiniksa Pharmaceuticals position peaked at $1.87M in Q3 2024.
  • 189 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2025.

Based on HighVista Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.